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BaCKgRoUND aND aIMS: The gap between patients on 
transplant waiting lists and available donor organs is steadily 
increasing. Human organoids derived from leucine-rich repeat-
containing G protein-coupled receptor 5 (LGR5)–positive 
adult stem cells represent an exciting new cell source for liver 
regeneration; however, culturing large numbers of organoids 
with current protocols is tedious and the level of hepatic dif-
ferentiation is limited.
appRoaCH aND ReSUltS: Here, we established a 
method for the expansion of large quantities of human liver 
organoids in spinner flasks. Due to improved oxygenation in 
the spinner flasks, organoids rapidly proliferated and reached 
an average 40-fold cell expansion after 2 weeks, compared 
with 6-fold expansion in static cultures. The organoids re-
populated decellularized liver discs and formed liver-like tis-
sue. After differentiation in spinner flasks, mature hepatocyte 
markers were highly up-regulated compared with static or-
ganoid cultures, and cytochrome p450 activity reached levels 
equivalent to hepatocytes.
CoNClUSIoNS: We established a highly efficient method 
for culturing large numbers of LGR5-positive stem cells in 
the form of organoids, which paves the way for the applica-
tion of organoids for tissue engineering and liver transplanta-
tion. (Hepatology 2020;0:1-14).
Liver disease and the subsequent loss of liver function is a major global health care chal-lenge with poor long-term clinical outcome. 
The only curative treatment for end-stage liver fail-
ure is transplantation; however, available donor organs 
are limited, and the number of patients on the trans-
plant wait list is steadily increasing. Approximately 
13,000 patients are currently on the transplant wait 
list in the United States, which far exceeds the num-
ber of available donor organs. According to the Organ 
Procurement and Transplantation Network, only 8,250 
livers were transplanted in 2018, and 20% of patients 
on the liver transplant wait list die or become too ill 
to be transplanted. This increasing shortage of donor 
organs demands the development of new techniques 
to replace damaged or severely diseased livers.(1)
Alternatives to liver transplantation include liver cell 
therapy and liver tissue engineering. Current approaches 
rely on primary hepatocytes. However, fully differenti-
ated hepatocytes are difficult to work with, as they exhibit 
minimal growth in culture and rapidly dedifferentiate 
in vitro.(2) This has led to the search for a renewable 
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source of stem cells that can be expanded in vitro and 
subsequently differentiated into hepatocyte-like cells.(3) 
Several such cell types include human pluripotent stem 
cells such as embryonic stem cells(4) or induced plurip-
otent stem (iPS) cells,(5) which have been investigated 
extensively. With these sources, an unlimited supply of 
human hepatocytes could be envisioned; however, gen-
eration and maintenance of stable and mature adult liver 
cells ex vivo have not yet been achieved.(6,7)
Another attractive alternative are organoids generated 
from leucine-rich repeat-containing G protein-coupled 
receptor 5 (LGR5)–positive adult tissue stem cells. 
Organoids offer exciting new possibilities as an autolo-
gous cell source for tissue engineering or cell therapy,(3,8) 
as they can be obtained easily from a liver biopsy and 
expanded in culture for years while remaining genetically 
stable.(9,10) Unfortunately, reproducibility and upscal-
ing of current organoid systems remain major bottle-
necks in their clinical application.(11) Establishing large 
numbers of organoids with current protocols is tedious, 
as organoids are cultured in droplets of Matrigel,(9,10) 
which hampers clinically relevant production times of 
organoids for tissue engineering and transplantations. It 
is estimated that the adult human liver contains about 
240  billion (109) hepatocytes,(12) and although trans-
plantation studies show that replacing 10% of the liver 
mass results in clinical improvement,(13) billions of cells 
are still required for clinical application.(14)
To enable mass production of viable cell cultures, 
bioreactors, including spinner flasks, have been used 
extensively for the large-scale expansion and con-
trolled differentiation of stem cells.(15,16) Bioreactors 
offer certain advantages including minimization of 
gradient formation (e.g., pH, nutrients, metabolites, 
dissolved oxygen), increased transport of oxygen and 
nutrients, and prevention of cell sedimentation, thus 
overcoming the intrinsic limitations of static culture 
systems.(17) As an example, Lancaster et al. clearly 
demonstrated limited growth potential of brain 
organoids due to stationary diffusion of oxygen and 
nutrients in static Matrigel cultures, and the use of 
spinner flasks markedly improved organoid survival 
and development.(18)
In this study, we used spinner flasks for the large-
scale production of human adult stem cell–derived liver 
organoids. We then examined the differentiation poten-
tial of the organoids toward functional hepatocytes, and 
assessed their use for tissue engineering approaches.
Experimental Procedures
oRgaNoID CUltURe aND 
DIFFeReNtIatIoN IN SpINNeR 
FlaSKS
Disposable 125-mL spinner flasks (Corning, 
New York, NY) were inoculated with 2.5  million 
cells in 25  mL expansion medium (EM), including 
10% vol/vol Matrigel. Due to single cell seeding, 
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10 mM Y-27632 (Rho kinase-inhibitor; Selleckchem, 
Munich, Germany) was added to the medium during 
the first week of culture. Rotation speed was set to 
85  rpm. Every 2-3  days, new medium was added to 
the spinner flasks.
For hepatic organoid differentiation in spinner 
flasks, organoids were primed for 2  days with the 
addition of bone morphogenetic protein 7 (BMP-
7; 25  ng/mL) to the EM. Subsequently, to separate 
organoids from the EM, the organoid suspension was 
filtered through a 70-µm cell strainer. The organ-
oids were transferred to a new spinner flask and 
differentiated for 12  days in human organoid dif-
ferentiation medium (DM) supplemented with 10% 




LiverPool cryoplateable hepatocytes (Admixed 
from 10 donors, mixed gender) were purchased 
from BioreclamationIVT (Brussels, Belgium). The 
hepatocytes were brought into a collagen sandwich 
culture according to the manufacturer’s instructions, 
with the recommended InvitroGRO CP Medium 
(BioreclamationIVT). For mRNA sequencing, 
alpha-1-antitrypsin (A1AT) and glutamate dehydro-
genase (GLDH) expression and albumin (ALB) secre-
tion assays, hepatocytes, and medium were harvested 
after 4  hours of sandwich culture. For midazolam 
metabolism assays, the medium from hepatocytes cul-
tured in collagen sandwich culture with 5 mM midaz-
olam was collected after 24 hours.
FReSH HepatoCyte ISolatIoN
Hepatocytes were obtained from healthy liver 
parenchyma from 2 patients with liver papilloma 
and adenoma, ages 40 and 41 years, respectively, 
undergoing liver resections. The hepatocytes were 
isolated by a modified two-step collagenase per-
fusion technique, as described.(30) The cells were 
snap-frozen directly after isolation. The procedure 
was in accordance with the ethical standards of 
the institutional committee on human experimen-
tation (protocol number 03/024) and the Helsinki 
Declaration of 1975. Informed consent in writing 
was obtained from each patient.
WHole tRaNSCRIptoMe 
aNalySIS
For mRNA sequencing, organoids, LiverPool 
cryoplateable hepatocytes, and freshly isolated 
hepatocytes were used. RNA was isolated using 
the RNeasy Mini Kit (Qiagen, Hilden, Germany) 
according to the manufacturers instructions. The 
polyadenylated mRNA fraction was isolated 
using Poly(A) Beads (NEXTflex; Bio Scientific, 
Austin, TX). The Rapid Directional RNA-Seq Kit 
(NEXTflex) was used to prepare sequencing libraries. 
Illumina NextSeq500 sequencing produced single- 
end 75 base long reads. RNA-sequencing reads 
were mapped using STAR version 2.4.2a. Read 
groups were added to the BAM files with Picard’s 
AddOrReplaceReadGroups (v1.98) and sorted with 
Sambamba v0.4.5. Transcript abundances were quan-
tified with HTSeq-count version 0.6.1p1, using the 
union mode. The raw files were uploaded to Gene 
Expression Omnibus under the accession GSE12 
3498. Differentially expressed genes were identified 
using the DESeq2 package with standard settings. 
Genes with a threshold fold change of four or more 
in all spinner flasks compared with their respective 
static controls were used for pathway analysis and 
visualization in heatmaps.
ToppFun was used for functional enrichment 
analysis based on functional annotations and protein 
interaction networks. Heatmaps were generated using 
edgeR.
DeCellUlaRIZeD lIVeR DISC 
pRepaRatIoN
Preparation of decellularized rat liver discs was per-
formed as previously described(22) and is outlined in 
the Supporting Experimental Procedures.
ReCellUlaRIZatIoN oF lIVeR 
DISCS WItH oRgaNoIDS
The seeding procedure was performed as previ-
ously described.(22) Briefly, organoids were mechani-
cally disrupted, and for each disc, organoid fragments 
corresponding to 2.5  ×  105 cells were suspended in 
10  μL EM supplemented with 25  ng/mL BMP-7. 
The organoid suspension was slowly pipetted on 
top of each disc and incubated for 1 hour at 37°C 
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to allow the cells to attach. Subsequently, 250 μL of 
additional EM with 25 ng/mL BMP-7 was added to 
each well. Medium was changed twice per day. After 
2 days of culture, the discs were carefully transferred 
to a 24-well plate and cultured in DM for 5 days. DM 
was refreshed after 2 days.
RNa ISolatIoN aND 
QUaNtItatIVe Rt-pCR
RNA was isolated from organoids, hepatocytes, 
and recellularized discs using the RNeasy Micro 
Kit according to the manufacturers instructions. 
For isolating RNA from the recellularized discs, we 
added the lysis buffer (RLT buffer from the RNeasy 
Micro Kit) to the discs, and after cell lysis, we trans-
ferred the lysate to a new tube and continued with 
the RNA isolation according to the RNeasy Micro 
Kit protocol. RNA was quantified by optical den-
sity. Complementary DNA (cDNA) was synthe-
sized using the iScript cDNA synthesis kit (Bio-Rad, 
Hercules, CA) as described by the manufacturer. 
Relative mRNA abundance of the selected genes was 
measured by real-time PCR using validated primers 
(Supporting Table S5) with the SYBR Green method 
(Bio-Rad). Messenger RNA abundances of the ref-
erence genes hypoxanthine-guanine phosphoribo-
syltransferase (HPRT) and ribosomal protein L19 





An overview of the used antibodies, dilutions, incu-
bation times, and antigen retrieval method are listed in 
Supporting Table S6, and the procedure is extensively 
described in the Supporting Experimental Procedures.
alB SeCRetIoN aND 
MIDaZolaM MetaBolISM 
aSSayS
To determine ALB secretion and midazolam 
metabolism, liver organoids were differentiated 
for 12  days as described. For spinner flask samples, 
organoids were harvested from spinner flasks at day 
12 of differentiation, seeded in Matrigel droplets and 
cultured in DM for 24  hours, after which the cul-
ture medium was collected and concentrated using 
Amicon Ultra centrifugal filters (Amicon, Darmstadt, 
Germany). The concentration of ALB was then deter-
mined using a DxC-600 Beckman chemistry analyzer 
(Beckman Coulter). Values were normalized for cell 
counts.
Midazolam metabolism was determined as a read-
out for cytochrome p450 3A4 (CYP3A4) function-
ality. Organoids were harvested from spinner flasks 
at day 12 of differentiation, seeded in Matrigel drop-
lets and cultured in DM supplemented with 5  mM 
midazolam. After 24  hours, medium was harvested 
and the concentration of the midazolam metabolite 
1-hydroxymidazolam (1-OH-M) was determined 
using liquid chromatography–tandem mass spectrom-
etry (LC/MS-MS). Analysis was carried out at the 
Clinical Pharmaceutical and Toxicological Laboratory 
of the Department of Clinical Pharmacy of the 
University Medical Center Utrecht, the Netherlands. 
All experiments were performed on a Thermo 
Fisher Scientific (Waltham, MA) triple quadrupole 
Quantum Access LC/MS-MS system with a Surveyor 
MS pump and a Surveyor Plus autosampler with an 
integrated column oven. Analytes were detected using 
tandem mass spectrometry, with an electrospray ion-
ization interface in selected reaction monitoring mode, 
by their parent and product ions.
RHoDaMINe 123 tRaNSpoRt 
aSSay
For rhodamine 123 (Rh123) transport assays, 
liver organoids were differentiated for 12  days as 
described. For spinner flask samples, organoids were 
harvested from spinner flasks at day 12 of differen-
tiation and seeded in Matrigel droplets. Organoids 
were pretreated with DMSO or 10  μM Verapamil 
(Sigma-Aldrich, St. Louis, MO) for 30  minutes. 
Organoids were then removed from Matrigel and 
incubated with 100  μM Rh123 (Sigma-Aldrich) 
for 10  minutes. Fluorescence was visualized by an 
EVOS FL Cell Imaging System (Life Technologies, 
Carlsbad, CA).
glDH aND a1at eXpReSSIoN
For the quantification of intracellular levels of 
GLDH and A1AT, liver organoids were differentiated 
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for 12  days, as described. For spinner flask samples, 
organoids were harvested from spinner flasks at day 
12 of differentiation, seeded in Matrigel droplets and 
cultured in DM for 24  hours. All wells were then 
trypsinized for cell counts. Subsequently, cells were 
lysed in MilliQ water. GLDH was measured in the 
lysates using a DxC-600 Beckman chemistry ana-
lyzer (Beckman Coulter). A1AT was measured using 
an AssayMax A1AT enzyme-linked immunosorbent 
assay kit (AssayPro, St. Charles, MO). Values were 
normalized to live cell numbers.
aMMoNIUM elIMINatIoN aSSay
For ammonium elimination assays, liver organoids 
were differentiated for 12 days, as described. For spinner 
flask samples, organoids were harvested from spinner 
flasks at day 12 of differentiation and seeded in Matrigel 
droplets. All conditions were then incubated with DM 
supplemented with 1.5 mM NH4Cl for 24 hours. All 
medium samples were harvested after 24 hours of incu-
bation and stored at −20°C. Subsequently, all wells were 
trypsinized, and the number of living cells per well was 
determined by counting with trypan blue. Ammonium 
concentrations in the medium were determined using 
the Urea/Ammonia Assay Kit  (Megazyme; Bray, 
County Wicklow, Ireland). DM supplemented with 
1.5 mM NH4Cl that was incubated for 24 hours with-
out cells was used to determine the starting concen-
tration. Ammonia elimination rates were normalized to 
live cell numbers.
MoUSe XeNogRaFt StUDIeS
All mouse experiments have been regulated under 
the Erasmus MC license for experimental animals 
(AVD101002017867/17-867-19). The mice were 
housed in individually ventilated cages with standard 
bedding, enrichment with tissues and ad libitum pellets.
For subcutaneous grafts, organoid fragments 
equal to 1 and 5 million cells were suspended in 1:1 
Matrigel:Advanced DMEM/F12 and were injected 
into four flank injection sites per female NOD.
Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice (Charles 
River, Wilmington, MA). Two mice were injected with 
organoids at the age of 10 weeks during the light cycle. 
As a positive control, human tumoroid liver organoids 
derived from a cholangiocarcinoma of a 76-year old 
female donor were used.(33) Visible tumors developed 
in approximately 8 weeks (tumoroid liver organoids), 
at which point the mice were euthanized and skin tis-
sues were harvested to assess the growth and histology 
of the grafted cells. Samples were fixed in 4% para-
formaldehyde overnight at room temperature, embed-
ded in paraffin, sectioned at 4 μm and processed for 
immunofluorescent analysis as described previously.
StatIStICal aNalySeS
Quantitative RT-PCR results (Fig. 4B), ALB 
secretion (Fig. 4E), A1AT expression (Fig. 4F), 
midazolam metabolism (Fig. 4G), GLDH expres-
sion (Fig. 4H), ammonium elimination (Fig. 4I) and 
mRNA sequencing data (Supporting Tables S2-S4) 
were analyzed using a one-tailed (unpaired) Mann-
Whitney U test. The P values are indicated in the 
corresponding figures and tables.
Data Availability Statement
All of the transcriptome data sets generated and 
analyzed during the current study are available in 
the Gene Expression Omnibus repository under the 
accession GSE12 3498. Other data sets generated 
and analyzed during the current study are avail-
able from the corresponding author on reasonable 
request.
Results
HUMaN lIVeR oRgaNoIDS aRe 
HIgHly pRolIFeRatIVe IN 
StIRReD SUSpeNSIoN CUltURe
To establish a suspension culture for efficient 
organoid expansion, we inoculated spinner flasks with 
105 human liver organoid cells per milliliter of organ-
oid EM(10) supplemented with 10% (vol/vol) Matrigel, 
cultured the cells for 2 weeks, and compared the pro-
liferation with that of cells conventionally cultured in 
Matrigel droplets (static controls; 105  cells/100  µL 
Matrigel). Light microscopy showed that the single 
cells grew out to form organoids within the first 4 days 
of culture in both static controls and spinner flasks 
(Fig. 1A). From culture day 7 onward, the diameter 
of the organoids in the spinner flasks increased and 
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FIg. 1. Enhanced liver organoid expansion in spinner flasks. Spinner flasks were inoculated with 2.5  ×  106 single organoid cells 
(105  cells/mL) at day 0 and cultured in human organoid EM supplemented with the Rho kinase inhibitor Y27632 and 10% vol/vol 
Matrigel; 4-5 different donors were analyzed in independent experiments. As controls, single cells were seeded in Matrigel droplets 
(105 cells/100 µL Matrigel) and cultured in EM supplemented with Y27632. (A) Light microscopy images of organoids grown from single 
cells in spinner flasks or in static control. (B) In vitro growth curves. An aliquot of cells was counted every 2-3 days, and cell numbers 
relative to day 0 were calculated. Each red dot represents a different donor. Blue dots represent the corresponding donors cultured in 
static control. Lines represent the mean of five different donors. (C) Ki67 stainings confirmed that organoids were highly proliferative 
at day 14 after seeding in spinner flasks and controls. (D) Long-term in vitro growth curves. Organoids from four different donors were 
cultured for 6 weeks in spinner flasks. Cultures were split every 2 weeks, and new spinner flasks were inoculated with organoid fragments 
corresponding to 2.5 × 106 cells. An aliquot of cells was counted every week, and theoretical total cell numbers were calculated. (E) mRNA 
sequencing data from organoids from three different donors that were cultured in spinner flasks or in static control for 14 days. Heatmaps 
show the three major pathways that were differentially regulated in spinner flask organoids compared with static controls. Abbreviations: 
SC, static control; SF, spinner flask.
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the outer cell layers appeared thicker compared with 
those in static controls. This was confirmed in histo-
logical sections, where spinner flask organoids often 
consisted of a multilayer of cells, whereas organoids 
in static controls consisted of a single epithelial layer 
(Fig. 1C). On day 14, organoid sizes were heteroge-
neous, with those in the spinner flasks clearly larger 
compared with those in static controls. The biggest 
organoids reached a diameter of about 5  mm in 
the spinner flasks and 1 mm in the static controls 
(Fig. 1A).
To quantify the cells, we harvested an aliquot from 
the spinner flasks every 2 to 3 days, and trypsinized 
and counted the single cells. Expansion rates varied 
between donors, but were significantly increased in 
spinner flasks compared with static controls for all 
five donors that were analyzed in independent exper-
iments (Fig. 1B). The average cell expansion after 
2 weeks was 43-fold in spinner flasks and 6-fold in 
static controls (Fig. 1B). Relative cell numbers for 
each donor are provided in Supporting Table S1. 
Immunohistochemical staining for Ki67 confirmed 
that almost every cell in the spinner flasks was 
proliferative (Fig. 1C), and quantitative RT-PCRs 
showed comparable expression of the stem cell 
marker LGR5 in spinner flasks and static controls 
(Supporting Fig. S1A). We next analyzed whether 
the stem cell phenotype and the high proliferation 
of the organoids were sustainable over several weeks, 
to obtain billions of cells as required for transplanta-
tions or tissue engineering. We inoculated four inde-
pendent spinner flasks with single cells from four 
different donors and passaged the organoids every 
2 weeks. After passaging, one new spinner flask per 
donor was inoculated with organoid fragments equal 
to a density of 105  cells/mL and expanded in EM. 
Quantitative RT-PCR showed that the expression of 
LGR5 in spinner flasks samples remained stable over 
the course of 6 weeks (Fig. S1B). For quantification 
of the cells, an aliquot from the spinner flasks was 
trypsinized and single cells were counted every week. 
We observed an exponential cell expansion during 
the 6 weeks of culture for organoids from all four 
donors. The calculation of the theoretical number of 
cells after 6 weeks of culture revealed a total amount 
of cells ranging between 5.1  ×  1010 and 2.7  ×  1012, 
depending on the donor (Fig. 1D). Therefore, with 
a starting number of 2.5  million cells, our method 
allowed us to produce sufficient numbers of cells to 
restore 17%-900% of the liver mass of an adult per-
son in only 6 weeks.
To assess what caused the high proliferation rate in 
the spinner flasks, we performed mRNA sequencing 
on organoids from three different donors that were 
cultured in spinner flasks or in Matrigel droplets for 
14 days. We selected genes that were down-regulated 
or up-regulated more than 4-fold in the spinner flasks 
compared with their respective static controls, and 
obtained a list of 69 annotated down-regulated genes 
(Supporting Table S2) and 62 annotated up-regulated 
genes (Supporting Table S3) that were overlapping for 
organoids from all three donors. Gene ontology anal-
ysis of those genes revealed that three major pathways 
were differentially regulated in spinner flask organ-
oids compared with static controls: cell cycle genes 
(n  =  19) were significantly up-regulated; and genes 
related to cell adhesion (n = 17) and genes related to 
hypoxia (n = 14) were significantly down-regulated in 
the spinner flask organoids (Fig. 1E and Supporting 
Tables S2 and S3), suggesting that the increased 
expansion rate in the spinner flasks may be associated 
with an improved oxygen supply.
SpINNeR FlaSK oRgaNoIDS Do 
Not FoRM tUMoRS IN VIVO
Because the spinner flask organoids were highly 
proliferative and genes related to cell cycle progression 
were highly expressed, we wondered how the organ-
oids would behave in vivo, particularly with regard to 
tumorigenic potential. We therefore performed xeno-
grafts in immune-deficient NSG mice. Organoids 
from two independent donors were harvested after 
8 weeks of culture in spinner flasks. Subsequently, 1 
and 5 million organoid cells from each donor were 
injected subcutaneously into the flanks of two NSG 
mice. As a positive control, we injected human liver 
cancer organoids derived from a cholangiocarci-
noma. After approximately 8 weeks, the site that was 
injected with the tumoroid liver organoids had a vis-
ible tumor and the mice were euthanized. We found 
many keratin 19 (K19)-positive liver structures in the 
tumor organoid–injected skin; only one K19 positive 
organoid was found back in skin transplanted with 
organoids derived from a single spinner flask donor 
(Fig. 2). None of the other injection sites showed any 
K19-positive structures. The tumor organoids stained 
positive for Ki67, showing proliferation in vivo. In 
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contrast, no Ki67 staining was seen in the one spinner 
flask organoid that was found back in the skin tissue, 
indicating that the surviving cells were quiescent, and 
not proliferative (Fig. 2).
SpINNeR FlaSK oRgaNoIDS 
RepopUlate DeCellUlaRIZeD 
lIVeR DISCS
Because mRNA sequencing analysis revealed that 
a group of genes related to cell adhesion was signifi-
cantly down-regulated in the spinner flask organoids 
compared with the static controls (Fig. 1E), we inves-
tigated whether the spinner flask organoids were able 
to engraft, a crucial requirement for clinical applica-
tion of organoids. We therefore seeded the spinner 
flask organoids on decellularized rat liver discs. We 
and others had previously shown that primary hepato-
cytes,(19) human liver stem/progenitor cells,(20-22) and 
induced hepatocyte-like cells(23) can repopulate decel-
lularized liver tissue. We harvested organoids after 
14  days of expansion in spinner flasks, mechanically 
dissociated them and seeded organoid fragments onto 
decellularized rat liver discs. After 1 week of culture 
in DM, the organoid cells had repopulated the discs, 
were viable and had adapted a columnar shape, with 
the nuclei on the extracellular matrix (ECM) side 
(Fig. 3A). Analysis of the discs by immunofluorescent 
staining revealed that we had different cell populations 
on the discs, which we quantified: Most of the cells 
(56%) showed a K19+/ keratin 18 (K18−) cholangiocyte- 
like phenotype (Fig. 3B), and 28% were K19/SRY-
box 9 (SOX9) double positive (Fig. 3C), 22% of 
cells had an intermediate K19+/K18+ phenotype (Fig. 3B), 
and only a minority of the cells (10%) were K18+/
hepatocyte nuclear factor-4-alpha hepatocyte-like 
cells (Fig. 3D). This indicates that organoids seeded 
on decellularized discs clearly interact with the ECM, 
adapt a columnar shape, and can obtain either a 
cholangiocyte-like or a hepatocyte-like fate, as such prov-
ing the true bipotential nature of these organoids and 
their great potential for tissue engineering approaches.
SpINNeR FlaSK oRgaNoIDS 
SHoW INCReaSeD HepatoCyte 
DIFFeReNtIatIoN aND 
FUNCtIoN
We previously showed that human liver organoids 
can be differentiated toward hepatocyte-like cells fol-
lowing change of medium conditions to DM, in which 
growth stimuli R-spondin and forskolin are removed, 
and N-[(3,5-difluorophenyl)acetyl]-l-alanyl-2-phenyl] 
glycine-1,1-dimethylethyl ester, fibroblast growth 
FIg. 2. Spinner flask organoids do not form tumors in vivo. Organoids from two independent donors were harvested after 8 weeks of 
culture in spinner flasks. Subsequently, organoids equal to 1 and 5 million cells from each donor were injected subcutaneously into NSG 
mice, as were human liver cancer organoids derived from a cholangiocarcinoma as a positive control. HE stainings and immunofluorescent 
analysis of paraffin-embedded injection sites are shown. A single K19-positive organoid was found back in the skin transplanted with 
spinner flask organoids, but no Ki67-positive nuclei were seen. All other injection sites did not show any K19-positive structures. 
Abbreviation: DAPI, 4′,6-diamidino-2-phenylindole.
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factor 19, dexamethasone, and BMP-7 are added.(10) 
However, the expression of differentiation markers in 
DM organoids was still significantly lower compared 
with hepatocytes. We reasoned that differentiation 
might be improved in our spinner flask organoids due 
to a more homogenous supply of oxygen and growth 
factors. Therefore, after 11 of days of culture in EM 
(to which BMP-7 was added for the last 2 days), we 
recovered the organoids in a cell strainer and trans-
ferred them to a new spinner flask containing DM. 
Light microscopy and hematoxylin and eosin (HE) 
staining of the differentiated organoids at day 5 
FIg. 3. Tissue formation of spinner flask organoids on liver ECM. (A-D) Organoids were expanded in spinner flasks for 14 days and then 
seeded on decellularized rat liver discs. Reseeded discs were cultured for 2 days in EM supplemented with BMP-7 and then differentiated 
for 5 days in human organoid DM. Four different donors (2-3 discs per donor) were analyzed in independent experiments. HE stainings 
(A) and immunofluorescent analysis (B-D) of paraffin-embedded organoids and liver discs are shown. Note that K18+ and HNF4a+ 
cells were not present in the organoids at the time of seeding on decellularized discs. (E) Quantification of the different cell populations. 
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revealed that the spinner flask organoids had a more 
folded morphology compared with control organoids 
(Fig. 4A). Immunohistological analysis for Villin-1 
demonstrated that the spinner flask organoids in gen-
eral had the same polarization as the control organoids, 
with the Villin-positive canalicular membrane facing 
the inside of the organoids, and the Villin-negative 
sinusoidal membrane facing the outside (Fig. 4A). 
However, polarization in the spinner flask organoids 
was less defined compared with control organoids (Fig. 
4A); in particular, some of the larger and highly folded 
organoids displayed mixed polarization (Supporting 
Fig. S2), putatively due to less stable adjacent polariz-
ing Matrigel concentrations when compared with static 
cultures in Matrigel droplets. Analysis of the organ-
oids by quantitative RT-PCR at different timepoints 
of differentiation confirmed that the stem cell marker 
LGR5 was down-regulated in all samples (Fig. 4B). In 
contrast, several hepatocyte markers such as CYP3A4, 
ALB, and multidrug resistance-associated protein 2 
(MRP2) were up-regulated, and were significantly 
higher expressed in the spinner flasks compared with 
static controls (Fig. 4B). Importantly, ALB transcript 
levels reached on average about 3%-4% of hepatocyte 
transcript levels, and those of CYP3A4 and MRP2 were 
higher in the spinner flask organoids than in hepato-
cytes. As a comparison, our previously published pro-
tocol for organoid differentiation in Matrigel droplets 
resulted in ALB levels of about 0.1% and CYP3A4 lev-
els of about 10% of liver tissue.(10) To obtain a more 
general overview of the expression patterns of our 
spinner flask organoids, we then performed mRNA 
sequencing on organoids from three independent 
donors at days 5 and 12 of differentiation. Principal 
component analysis for all samples showed that the 
spinner flask samples clustered together and were 
closer to primary hepatocytes than the static control 
samples (Supporting Fig. S3). We then selected genes 
that were up-regulated more than 4-fold in the spin-
ner flasks at day 12 of differentiation compared with 
their respective static controls, and obtained a list of 
105 genes (99 annotated genes) that overlapped across 
all three donors. Gene ontology analysis revealed that 
more than 30% of those genes were directly related to 
liver functions, such as the cytochrome p450 (CYP) 
pathway and lipid, drug, hormone, and alcohol metab-
olism (Fig. 4C and Supporting Table S4).
Finally, we analyzed the functionality of the differ-
entiated spinner flask organoids using several assays. 
First, we incubated organoids with Rh123, a fluores-
cent chemical compound that can be actively secreted 
from hepatocytes by MDR1. We observed fluores-
cence accumulation inside the lumen of the organoids 
for both static controls and spinner flasks (Fig. 4D). 
In contrast, Rh123 was retained in the cytoplasm of 
the cells when organoids had been pretreated with 
the competitive MDR1 inhibitor Verapamil, confirm-
ing the MDR1-specific transport of Rh123. Another 
characteristic of hepatocytes is glycogen storage. 
During a feeding state, glucose enters the hepatocytes 
and is synthesized to glycogen, which can then be 
hydrolyzed to generate glucose during a fasting state. 
Periodic acid–Schiff staining for glycogen confirmed 
that differentiated organoids from static conditions 
and spinner flasks showed large intracellular accu-
mulations of glycogen (Fig. 4D). Another important 
function of hepatocytes is the production of serum 
proteins; therefore, we determined ALB secretion and 
the expression of A1AT of the organoids at day 12 
of differentiation. Compared with static controls, we 
FIg. 4. Organoid differentiation into functional hepatocytes in spinner flasks. Organoids were differentiated in spinner flasks or under 
static controls for 12  days. (A) Light microscopy images, HE stainings, and immunohistochemical analyses of paraffin-embedded 
organoids for the canalicular marker Villin-1. Nuclei were counterstained with hematoxylin. Expression of hepatocyte markers in 
differentiated organoids, determined by quantitative RT-PCR (B) and mRNA-sequencing (C). (B) Transcript levels of LGR5, CYP3A4, 
ALB, and MRP2. Graphs indicate five independent experiments for five different donors. Cryopreserved hepatocytes were used as 
positive control. (C) mRNA sequencing on organoids from three independent donors at day 12 of differentiation. Genes that were more 
than 4-fold up-regulated in the spinner flasks at day 12 of differentiation compared with the respective static controls are shown in a 
heatmap. Some well-known hepatic genes are annotated. For a full list of genes and their liver-related functions, see Supporting Table 
S4. (D) Rh123 transport was determined as readout for MDR1 activity, and PAS staining indicates glycogen storage in organoid cells. 
(E-I) Hepatocyte functionality of spinner flask organoids was assessed. Three independent donors were analyzed in three independent 
experiments. Graphs indicate mean ± SD. Cryopreserved hepatocytes cultured for 24 hours in standard sandwich culture served as a 
positive control. ALB concentration in supernatant (E) and intracellular A1AT levels (F). Midazolam metabolism (G) was determined as 
readout for CYP3A4 functionality. Intracellular GLDH levels (H) and ammonium elimination (I) from the culture medium. *P ≤ 0.05. 
Abbreviations: ADH, alcohol dehydrogenase; BC01, beta-carotene oxygenase 1; G6PC, glucose-6-phosphatase catalytic subunit; MT2A, 
metallothionein 2A; OTC, ornithine carbamoyltransferase; PAS, Periodic acid–Schiff; SC, static control; SF, spinner flask; UGT2B17, 
UDP glucuronosyltransferase family 2 member B17.
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observed a significantly higher concentration of ALB 
in the spinner flask organoid medium, which reached 
about 8% of the concentration in the medium of cul-
tured hepatocytes (Fig. 4E). A1AT levels did not dif-
fer between spinner flask organoids and static controls 
(Fig. 4F). Another key function of hepatocytes is drug 
metabolism, with CYP enzymes as important players. 
To measure CYP activity in the organoids, we exposed 
differentiated organoids to 5  mM midazolam for 
24 hours, and then determined the concentration of the 
midazolam metabolite 1-OH midazolam in the culture 
medium. In spinner flask organoids, we observed that 
midazolam metabolism was induced to about 70% of 
the levels of hepatocytes (Fig. 4G). Finally, we assessed 
ammonium elimination from the medium by spinner 
flask organoids and static controls. Hepatocytes elim-
inate ammonia from the medium by urea cycle activ-
ity or fixation into amino acids. Ammonia reacts with 
α-ketoglutaric acid to l-glutamate. This reaction is 
catalyzed by l- GLDH. The expression of GLDH 
showed a higher trend in the spinner flask organ-
oids compared with static controls (Fig. 4H), and 
accordingly, ammonia elimination from the medium 
appeared to be more efficient in spinner flask organ-
oids compared with static controls (Fig. 4I).
Discussion
The shortage of available donor organs for patients 
on transplant wait lists highlights the need for alter-
natives to liver transplantation. Liver organoids from 
LGR5-positive adult tissue stem cells offer excit-
ing new possibilities for tissue engineering or cell 
transplantations.(3,8) However, the lack of reliable 
and reproducible methods for the expansion of liver 
organoids hampers clinical application in which bil-
lions of cells are needed. To restore 10%-20% of the 
hepatocyte liver mass of an adult, it is essential to cul-
ture an estimated 20-50 × 109 cells.(14)
In this study, we describe a robust spinner flask–
based method for large-scale culture of human LGR5-
positive adult stem cell–derived liver organoids. This 
method allows high proliferation levels, repopulation 
potential, and maturation toward cholangiocyte-like 
and hepatocyte-like cells. These cells do not induce 
tumor formation and can be serially passaged and 
maintained for at least 6 weeks (Fig. 1A-D). This 
greatly improves upon current techniques for the 
expansion of large numbers of liver stem cells, and 
therefore approaches to liver regeneration.
Our mRNA sequencing data suggest that the 
enhanced proliferation may be caused by an improved 
oxygen supply (and also probably growth factors) in 
spinner flasks (Fig. 1E). This hypothesis is strength-
ened by the observation that organoids at the edges of 
a Matrigel droplet usually grow larger compared with 
organoids in the middle of the droplet, where oxygen 
and growth factor supply may be restricted.
Importantly, Huch et al. have extensively analyzed 
the genetic stability of cultured organoids in vitro and 
showed that their genetic integrity is preserved over 
several months.(14) Because proliferation of our organ-
oids in spinner flasks was significantly increased com-
pared with conventional Matrigel culture, we assessed 
their behavior in vivo, and the lack of tumor formation 
suggests their promise for clinical application (Fig. 2). 
This is in strong contrast to hepatocyte-like cells 
derived from iPS cells, where genetic instability raises 
concerns regarding their safety in a clinical setting.(24)
We observed that expansion of organoids in spin-
ner flasks led to a significant down-regulation of adhe-
sion-related genes in the organoids (Fig. 1E), raising 
doubts about their capacity for engraftment in vivo, 
which is mediated by integrin-ECM interactions.(25) 
We therefore seeded the spinner flask organoids on 
decellularized liver discs,(22) and observed clear interac-
tion with the ECM as well as a columnar cell shape and 
selective differentiation toward both a cholangiocyte- 
like and a hepatocyte-like fate, indicating their bipo-
tential nature and great potential for tissue engineering 
approaches. Of note, only a minority of the cells obtained 
a K19−/K18+ hepatocyte phenotype, whereas the vast 
majority had a K19+/Sox9+ cholangiocyte phenotype or 
a K19+/K18+ intermediate phenotype (Fig. 3). This inef-
ficient hepatocyte differentiation may partly be explained 
by the origin of the decellularized liver discs used in this 
study, which were derived from rats and not from humans. 
Additionally, we foresee that the hepatocyte matura-
tion potential of the reseeded discs may be improved 
if organoids are seeded on human ECM and cultured 
under shaking conditions, for enhanced oxygenation and 
medium perfusion.(26) Although the organoids engrafted 
well in vitro, unfortunately we did not observe any 
in vivo engraftment of the spinner flask organoids after 
xenotransplantation in Fah−/−/Rag2−/−/Il2rg−/y (FRG) 
mice (Supporting Fig. S5). This might be explained by 
the fact that even though spinner flask differentiation 
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led to a more mature hepatocyte-like phenotype com-
pared with conventional Matrigel controls (Fig. 4), the 
organoids did not reach a fully mature hepatocyte phe-
notype. For example, ALB secretion reached only 8% of 
the concentration in the medium of cultured hepato-
cytes (Fig. 4E). A low ALB expression compared with 
other more mature hepatocyte markers is consistent 
with earlier observations of organoid differentiation(10) 
and suggests that organoids follow a sequence of dif-
ferentiation events that is different from the stages of 
fetal to mature hepatocyte development.(27) Remarkably, 
the late hepatocyte marker CYP3A4 reached expression 
levels equivalent to mature hepatocytes (Fig. 4B), intra-
cellular GLDH levels were comparable to hepatocytes 
(Fig. 4H), and midazolam metabolism was induced 
to about 70% of levels found in mature hepatocytes 
(Fig. 4G).
In conclusion, we have developed a method for highly 
efficient and safe expansion of LGR5-positive liver stem 
cells, enabling subsequent differentiation toward highly 
mature and functional hepatocyte-like cells. Interestingly, 
during the writing of this manuscript, culture conditions 
for the in vitro expansion of primary human hepato-
cytes in 2D(28) and primary mouse and human fetal 
hepatocytes as 3D organoids(29,30) have been established. 
Those in vitro expanded hepatocytes are a more efficient 
source for transplantations than the cholangiocyte- 
derived organoids described here, as hepatocyte matura-
tion generally correlates with transplantation efficiency. 
We expect that the spinner flask method could also be 
applied to those hepatocyte organoids and other types 
of adult stem cell–derived organoids, which may ben-
efit from an improved supply of oxygen and growth 
factors.(31) As a next step, we should seek to replace 
Matrigel in the spinner flasks by a defined and clinically 
suitable hydrogel, following the lead by Gjorevski et al., 
who recently published a major breakthrough by replac-
ing Matrigel with a modified PEG gel for the expansion 
and differentiation of intestinal organoids.(32) The major 
advantage of the spinner flask culture method is that we 
can reproducibly culture functional liver organoid cells 
in a time-, work-, and cost-efficient way, and the com-
bination of a clinically suitable hydrogel and the spinner 
flask method for the culture of adult stem cell–derived 
organoids will establish an avenue for clinical applica-
tions of organoids in the near future.
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